Drugs / HyaDent BG
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT06438354 | Aug 2022 → Oct 2023 | periodontal disorder | University of Witten/Herdecke | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT07230522 | Mar → Jul 2024 | periodontitis | Medical University of Sofia | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05990049 Comparator | Mar 2023 → Jan 2024 | gingival recession | University of Zagreb | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HyaDent BG | “Bio-Oss® Collagen combined with HyaDent® BG (cross-linked hyaluronic acid gel)” NCT07230522 ↗ |
| Modality | Other / unclassified | “Hyadent BG is a cross-linked hyaluronic acid.” NCT05990049 ↗ |